Human Gene MIR658 (ENST00000385210.1) from GENCODE V44
|
|
Sequence and Links to Tools and Databases
|
|
Primer design for this transcript
|
|
Microarray Expression Data
|
|
Press "+" in the title bar above to open this section.
| |
|
|
Orthologous Genes in Other Species
|
|
Orthologies between human, mouse, and rat are computed by taking the best BLASTP hit, and filtering out non-syntenic hits. For more distant species reciprocal-best BLASTP hits are used. Note that the absence of an ortholog in the table below may reflect incomplete annotations in the other species rather than a true absence of the orthologous gene.
Mouse | Rat | Zebrafish | D. melanogaster | C. elegans | S. cerevisiae |
No ortholog | No ortholog | No ortholog | No ortholog | No ortholog | No ortholog |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
| | | | | |
|
| |
|
|
Descriptions from all associated GenBank mRNAs
|
|
BC014641 - Homo sapiens ankyrin repeat domain 54, mRNA (cDNA clone MGC:15484 IMAGE:2988073), complete cds. BC066909 - Homo sapiens ankyrin repeat domain 54, mRNA (cDNA clone MGC:87097 IMAGE:4795922), complete cds. CR456471 - Homo sapiens dJ466N1.4 full length open reading frame (ORF) cDNA clone (cDNA clone C22ORF:pGEM.dJ466N1.4.V3). FV525871 - Nucleic acid controling mast cell degranulation. HZ408738 - JP 2015528002-A/1335: CHIRAL CONTROL. HZ462373 - WO 2015190591-A/528: Kit and method for detecting breast cancer. LG052072 - KR 1020150036642-A/1338: CHIRAL CONTROL. LY499376 - KR 1020170018412-A/528: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. MS880691 - Sequence 528 from Patent EP3156498. FV524321 - Nucleic acid controling mast cell degranulation. FW312418 - DETECTING NUCLEIC ACIDS. FW364571 - Oligonucleotides for modulating target RNA activity. HI964809 - Sequence 94 from Patent WO2010139812. HI965810 - Sequence 130 from Patent WO2010139811. HI966676 - Sequence 130 from Patent WO2010139810. HV595483 - JP 2010539959-A/864: Micromirs. HV938882 - JP 2011519579-A/1710: Oligonucleotides Containing Arabinose Modified Nucleotides For Treating Inflammation and Neoplastic Cell Proliferation. HV953987 - JP 2012518421-A/899: METHODS OF DETECTING LUNG CANCER. HW066211 - JP 2013000067-A/3: Composition and Method for Diagnosing Bladder Cancer. HZ074535 - JP 2013535982-A/626: Single-Stranded RNAi Agents Containing an Internal, Non-Nucleic Acid Spacer. HZ158040 - JP 2015130862-A/864: Micromirs. HZ186884 - JP 2015146814-A/633: Oligonucleotides for modulating target RNA activity. HZ462097 - WO 2015190591-A/252: Kit and method for detecting breast cancer. HZ482536 - JP 2015535430-A/3042: TERMINALLY MODIFIED RNA. HZ792467 - JP 2016504050-A/4212: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. JA400847 - Sequence 94 from Patent WO2011080318. JA401825 - Sequence 94 from Patent WO2011080315. JA402832 - Sequence 94 from Patent WO2011080316. JA405463 - Sequence 94 from Patent EP2336353. JA427175 - Sequence 508 from Patent WO2011072177. JA428989 - Sequence 94 from Patent WO2011095623. JA660762 - Sequence 216 from Patent WO2011131354. JA715117 - Sequence 899 from Patent EP2401406. JA757946 - Sequence 79 from Patent WO2012010584. JA791902 - Sequence 304 from Patent WO2012089772. JA792216 - Sequence 265 from Patent WO2012089753. JA821189 - Sequence 1710 from Patent EP2285961. JB022217 - Sequence 59 from Patent WO2013026685. JB022870 - Sequence 124 from Patent WO2013026684. JB074819 - Sequence 79 from Patent WO2012168448. JB620720 - Sequence 700 from Patent WO2013063544. JC037828 - Sequence 356 from Patent EP2643479. JC515199 - Sequence 5452 from Patent WO2014113089. JE978771 - Sequence 216 from Patent EP2865765. LF161224 - JP 2016513950-A/1290: Oligomers with improved off-target profile. LF632763 - WO 2016117582-A/192: miRNA biomarkers for mental disorders. LP726436 - Sequence 130 from Patent EP2883966. LP818706 - Sequence 130 from Patent EP3296406. LP938648 - Sequence 130 from Patent EP3184651. LQ072787 - Sequence 3111 from Patent EP2964234. LQ441072 - Sequence 79 from Patent EP3029157. LY405548 - KR 1020160117535-A/853: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. LY499100 - KR 1020170018412-A/252: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. LZ234241 - JP 2017184756-A/633: Oligonucleotides for modulating target RNA activity. MA260787 - JP 2017505623-A/853: POLY OLIGOMER COMPOUND WITH BIOCLEAVABLE CONJUGATES. MA405895 - WO 2018155427-A/669: A probe with reduced false positive binding, a method to desing the probe, and the use thereof. MA646288 - JP 2017113010-A/4212: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA734172 - JP 2017140048-A/3042: TERMINALLY MODIFIED RNA. MS673321 - Sequence 124 from Patent EP3135774. MS833948 - Sequence 94 from Patent EP3112479. MS880415 - Sequence 252 from Patent EP3156498. MS901586 - Sequence 59 from Patent EP3156505. HZ462678 - WO 2015190591-A/833: Kit and method for detecting breast cancer. LY499681 - KR 1020170018412-A/833: BREAST CANCER DETECTION KIT OR DEVICE, AND METHOD FOR DETECTING BREAST CANCER. MS880996 - Sequence 833 from Patent EP3156498. MA806104 - WO 2018199275-A/364: Kit, device and method for detection of ovary tumor. MA803341 - JP 2018183181-A/4212: SIGNAL-SENSOR POLYNUCLEOTIDES FOR THE ALTERATION OF CELLULAR PHENOTYPES. MA805828 - WO 2018199275-A/88: Kit, device and method for detection of ovary tumor. MA806376 - WO 2018199275-A/636: Kit, device and method for detection of ovary tumor. MA822621 - WO 2019004436-A/434: Kit, device, and method for detection of lung cancer. MA822284 - WO 2019004436-A/97: Kit, device, and method for detection of lung cancer. MA822968 - WO 2019004436-A/781: Kit, device, and method for detection of lung cancer.
| |
|
|
Other Names for This Gene
|
|
Alternate Gene Symbols: NR_030395, uc021wpj.1 UCSC ID: ENST00000385210.1 RefSeq Accession: NR_030395
| |
|
|
Methods, Credits, and Use Restrictions
|
|
Click here
for details on how this gene model was made and data restrictions if any.
| |
|
|
|